Literature DB >> 9240843

Idiopathic myelofibrosis (agnogenic myeloid metaplasia) in a marmoset (Callithrix jacchus): hematologic and histopathologic changes.

K N Khan, A C Logan, E M Blomquist.   

Abstract

Idiopathic myelofibrosis (IMF), or agnogenic myeloid metaplasia, was diagnosed in a sexually mature male marmoset (Callithrix jacchus) based on the results of hematology and histopathologic evaluation of the bone marrow. The hematologic changes included pancytopenia, leukoerythroblastosis, anisocytosis, poikilocytosis, and giant platelets. Histopathologic evaluation of the bone marrow showed marked widespread fibrosis replacing hematopoietic cells and the presence of atypical megakaryocytes. In addition, slight multifocal osteolysis with an increase in serum alkaline phosphatase activity was observed. We believe this is the first report of IMF in a nonhuman primate species.

Entities:  

Mesh:

Year:  1997        PMID: 9240843     DOI: 10.1177/030098589703400410

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  3 in total

Review 1.  Spontaneous mediastinal myeloid sarcoma in a common marmoset (Callithrix jacchus) and review of the veterinary literature.

Authors:  Danielle T Morosco; Curtis R Cline; Michael A Owston; Shyamesh Kumar; Edward J Dick
Journal:  J Med Primatol       Date:  2017-02-01       Impact factor: 0.667

2.  Osteosarcoma in Baboons (Papio spp).

Authors:  Marguerite J Mezzles; Edward J Dick; Michael A Owston; Cassondra Bauer
Journal:  Comp Med       Date:  2015-04       Impact factor: 0.982

3.  Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmoset.

Authors:  Victoria K Baxter; Gillian C Shaw; Nathaniel P Sotuyo; Cathy S Carlson; Erik J Olson; M Christine Zink; Joseph L Mankowski; Robert J Adams; Eric K Hutchinson; Kelly A Metcalf Pate
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.